Testing a new scale for thinking and mood problems in cerebellum disorders
Part of Brain & nervous system clinical trials.
This study tests a new questionnaire (CCASS) to screen for cognitive-affective syndrome in people with cerebellar damage. It aims to see if the French version works well to identify thinking and mood changes caused by cerebellar disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a cerebellar condition (from injury or disease)
- You speak French
- You have health insurance (social security) in France
- You agree to participate and sign a consent form
- You do not have other brain diseases (like stroke or dementia) not related to your cerebellum
- You do not have severe vision, hearing, or speech problems that would prevent you from taking the test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, minimally invasive brain stimulation technique for people with Cushing syndrome who have developed a condition called cerebellar cognitive affective syndrome (CCAS). It aims to improve both thinking skills and movement coordination.
This study tests a new way to measure movement and balance problems in people with ataxia (a condition that affects coordination) or after a stroke in the part of the brain that controls movement. The goal is to see if the scale gives consistent results across different raters, which could help doctors better monitor patients.
This study looks at how people with severe psychiatric conditions like schizophrenia, bipolar disorder, or depression perform on memory and thinking tests. It may help doctors understand these conditions better and tailor treatments.
This study is testing new questionnaires to better understand everyday thinking and memory problems in older adults. It aims to improve how doctors identify and track conditions like mild cognitive impairment and early dementia.
This trial checks a new kind of paper-and-pen (or computer-based) test to better measure thinking and social/behavior skills in people with certain brain diseases. It may help researchers improve how these skills are tracked and understood over time.
This study evaluates a test battery (ExéSem) that helps doctors understand how executive functions (like planning and problem-solving) contribute to language and meaning disorders. Participants will complete cognitive tasks, and the results may help improve diagnosis and care for people with certain memory or language conditions.
Hear when a new Cerebellar Cognitive-affective Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.